Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2010
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/23/2010WO2010148234A1 Sap variants and their use
12/23/2010WO2010147792A2 Compounds which selectively modulate the cb2 receptor
12/23/2010WO2010147677A2 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone
12/23/2010WO2010147440A2 Health food or pharmaceutical composition comprising chestnut shell extract
12/23/2010WO2010147184A1 Prophylactic and/or therapeutic agent for dysmenorrhea
12/23/2010WO2010147171A1 Chicken-derived anti-lox-1 antibody
12/23/2010WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof
12/23/2010WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor
12/23/2010WO2010146351A1 Indolylmethyl-morpholine derivatives as kinase inhibitors
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010146173A1 Quinazoline derivatives as histamine h4-recept0r inhibitors for use in the treatment of inflammatory disorders
12/23/2010WO2010146133A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010WO2010145800A1 Salts of tramadol and diflunisal and their crystal form in the treatment of pain
12/23/2010WO2010145208A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof
12/23/2010WO2010145197A1 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors
12/23/2010WO2010126528A9 Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
12/23/2010WO2010103130A3 Thiazolopyrimidine modulators as immunosuppressive agents
12/23/2010WO2010054278A3 Compounds for the treatment of inflammatory disorders
12/23/2010US20100325744 Non-glycosylated recombinant monovalent antibodies
12/23/2010US20100324529 Implant pellets and method using same
12/23/2010US20100324139 Process to pregabalin
12/23/2010US20100324132 Methods and compositions for promoting wound healing
12/23/2010US20100324118 Method for the Promotion of Angiogenesis, Vascularization, or Vascular Repair or for the Inhibition of Tumor Angiogenesis
12/23/2010US20100324111 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and aspragine, and use thereof in the tratment of atopic dermatitis
12/23/2010US20100324107 USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE
12/23/2010US20100324106 Compounds
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324089 Anti-inflammatory composition
12/23/2010US20100324088 Fused Pyridone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324086 Compounds and methods
12/23/2010US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/23/2010US20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds
12/23/2010US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324069 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324056 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324051 Novel compounds as opioid receptor modulators
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324036 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
12/23/2010US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/23/2010US20100324022 Novel compounds
12/23/2010US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324014 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324013 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324012 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324011 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323991 Methods and products for treatment of diseases
12/23/2010US20100323990 Ship 1 modulator prodrugs
12/23/2010US20100323987 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323976 Novel anti-inflammatory pro-drugs
12/23/2010US20100323974 Inhibitors of PARP Activity and Uses Thereof
12/23/2010US20100323970 Sap variants and their use
12/23/2010US20100323969 Compounds Binding to P-Selectin
12/23/2010US20100323964 New non-selective somatostatin analogues
12/23/2010US20100323961 Surface eroding sutures
12/23/2010US20100323960 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323959 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323958 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
12/23/2010US20100323042 Methods And Compositions For Treating Skin
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323036 Nitric Oxide Therapies
12/23/2010US20100323030 Composition with Anti-Inflammatory, Protein Synthesizing, Enzyme Deficiency Activating Genetic Therapy and Anti-Cancer Activity and Methods of Use
12/23/2010US20100323005 Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen
12/23/2010US20100322992 Anti-Proliferative And Anti-Inflammatory Agent Combination For Treatment Of Vascular Disorders With An Implantable Medical Device
12/23/2010US20100322989 Hydrophilic skin cleaning cloth
12/23/2010US20100322986 Compositions and devices
12/23/2010US20100322978 Medical composition
12/23/2010US20100322976 Tonic and food supplement comprising aloe vera and honey
12/23/2010US20100322974 Targeting the histone code as a bacterial strategy for selectively modulating gene expression
12/23/2010US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322928 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322894 Combination Therapies for Treating Type 1 Diabetes
12/23/2010US20100322862 Methods and compositions using peptides and proteins with c-terminal elements
12/23/2010DE102009025119A1 Herstellung und Verwendung antitumoraler, antibiotischer und insektizider Cyclodepsipeptide Production and use of antitumor, antimicrobial and insecticidal cyclodepsipeptides
12/23/2010CA2765847A1 Prophylactic and/or therapeutic agent for dysmenorrhea
12/23/2010CA2765525A1 Compounds which selectively modulate the cb2 receptor
12/23/2010CA2765479A1 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone
12/23/2010CA2765466A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010CA2765408A1 New crystalline form of pemirolast
12/23/2010CA2765394A1 Sap variants and their use
12/23/2010CA2763730A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264047A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
12/22/2010EP2264043A1 Heterobifunctional pan-selectin inhibitors
12/22/2010EP2264034A1 Bicyclic pyrrole compound
12/22/2010EP2264033A1 3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS
12/22/2010EP2264031A2 A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 1272